{
  "id": 4048376,
  "title": "Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera",
  "url": "https://urgent.news/2026/08/28/takeda-receives-u-s-fda-approval-of-mimrylotm-rusfertide-marking-a",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-28T22:45:01.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/takeda-receives-u-s-fda-approval-of-mimrylo-rusfertide-marking-a-potential-shift-in-the-treatment-paradigm-for-polycythemia-vera"
  },
  "original_language": "en",
  "account": null,
  "summary": "MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV) MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve Fatigue Approval Supported by Phase 3 VERIFY Results Showing 76.9% […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Medical Xpress",
        "title": "FDA approval opens new chapter in pancreatic cancer treatment",
        "url": "https://urgent.news/2026/08/28/fda-approval-opens-new-chapter-in-pancreatic-cancer-treatment",
        "published": "2026-08-28T12:00:02.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}